Swipe om te navigeren naar een ander artikel
To assess the quality of life (QOL) of persons who inject drugs.
Some 483 current injecting drug users visiting a large NSP over a 2-week period in October 2009 were interviewed using a structured questionnaire. QOL was measured using the WHOQOL-BREF. Data were collected on age, gender, injecting patterns, current drug treatment status and hepatitis C status. Participant QOL profiles were compared to published domain scores for a range of other population groups.
People who inject drugs (PWID) experience a very poor QOL irrespective of socio-demographic characteristics, injecting patterns, hepatitis C sero-status and drug treatment status. Sample participants (PWID) experience a QOL below that experienced by many population groups in the community affected by disabling chronic illnesses.
Injecting drug use is associated with a poor QOL. Some PWID may be self-medicating for chronic non-malignant pain, and it is likely that these people had a low QOL prior to the decision to inject. Despite this caveat, it remains likely that injecting drug use does little to enhance the QOL of the user.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Robinson, R. (2006). Health perceptions and health-related quality of life of substance abusers: A review of the literature. Journal of Addiction Nursing, 17, 159–168. CrossRef
Reference Group to the United Nations on HIV and Injecting Drug Use. (2010). Consensus statement of the Reference Group to the United Nations on HIV and Injecting Drug Use 2010: Summary of Recommendations.
Mathers, B., Degenhardt, L., Ali, H., Wiessing, L., Hickman, M., et al. (2008). The global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. The Lancet, 372, 1733–1745. CrossRef
Australian Institute of Health and Welfare. (2011). 2010 National Drug Strategy Household Survey Report, Australian Institute of Health and Welfare: Canberra.
Sepehrmanesh, Z., & Ahmadvand, A. (2009). Psychopathology of injecting abuser. American Journal of Addictions, 4, 332–333.
Kidorf, M., King, V. L., Peirce, J., Burke, C., Kolodner, K., et al. (2010). Psychiatric distress, risk behavior, and treatment enrollment among syringe exchange participants. Addictive Behaviours, 35, 499–503. CrossRef
Lemstra, M., Rogers, M., Thompson, A., Moraros, J., & Buckingham, R. (2011). Risk indicators of depressive symptomatology among injection drug users and increased HIV risk behaviour. Canadian Journal of Psychiatry, 56, 358–366.
Gibbie, T., Hides, L., Cotton, S., Lubman, D., Aitken, C., et al. (2011). The relationship between personality disorders and mental health, substance use severity and quality of life among injecting drug users. Medical Journal of Australia, 195, S16–S21. PubMed
Rooney, S., Freyne, A., Kelly, G., & O’Connor, J. (2007). Differences in the quality of life of two groups of drug users. International Journal Psychiatry Medicine, 19, 55–59.
Conroy, E., Kimber, J., Dolan, K. A., & Day, C. (2008). An examination of the quality of life among rural and outer metropolitan injecting drug users in NSW, Australia. Addiction Research and Theory, 16, 607–617. CrossRef
de Wit, J., Treloar, C., & Wilson, H., (eds). (2009). HIV/AIDS, hepatitis and sexually transmissilbe infections in Australia: Annual report of trends in behaviour 2009. National Centre in HIV Social Research, The University of New South Wales: Sydney.
National Centre for HIV Epidemiology and Clinical Research. (2010). Australian NSP survey national data report 2005–2009. Sydney: National Centre for HIV Epidemiology and Clinical Research, The University of New South Wales.
The WHOQOL Group. (1995). World Health Organization Quality of Life Group (WHOQOL): Position paper from the World Health Organization. Social Science and Medicine, 41, 1403–1440. CrossRef
Skevington, S. M., Lofty, M., & O’Connell, K. A. (2004). The World Health Organization’s WHOQOL-BREF: preliminary population norms and effect sizes. Social Indicators Research, 13, 299–310.
The WHOQOL Group. (1998). The World Health Organization quality of life assessments (WHOQOL): development and general psychometric properties. Social Science and Medicine, 46, 1569–1585. CrossRef
The WHOQOL Group. (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine, 28, 551–558. CrossRef
Murphy, B., Herman, H., Hawthorne, G., Pinzone, T., & Evert, H. T. (2000). The World Health Organization Quality of Life (WHOQOL) Study: Australian WHOQOL-100, WHOQOL-BREF, and CA-WHOQOL instruments—User’s manual and interpretation guide. Melbourne: WHO-QOL Field Study Centre, University of Melbourne.
Skevington, S. M., McCrate, F. M. (2012). Expecting a good quality of life in health: Assessing people with diverse diseases and conditions using the WHOQOL-BREF. Health Expectations, 49–62.
Barker, R. N., Kendall, M. D., Amsters, D. I., Pershouse, K. J., Haines, T. P., et al. (2009). The relationship between quality of life and disability across the lifespan for people with spinal cord injury. Spinal Cord Injury, 47, 149–155. CrossRef
Aigner, M., Forster-Streffleur, S., Prause, W., Friedl, M., Weiss, M., et al. (2006). What does WHOQOL-BREF measure? Measurement overlap between quality of life and depressive symptomology in chronic somatoform pain disorder. Social Psychiatry and Psychiatry Epidemiology, 41, 81–86. CrossRef
StataCorp. (2009). Stata statistical software. College Station, TX: StataCorp LP.
Connor, J., Saunders, J., & Feeney, G. (2006). Quality of life in substance use disorders. In H. Katschnig, H. Freeman, & N. Sartorius (Eds.), Quality of life in mental disorders. Hoboken, NJ: Wiley.
- Quality of life of people who inject drugs: characteristics and comparisons with other population samples
Jane A. Fischer
Alexandra M. Clavarino
Jackob M. Najman
- Springer Netherlands